ClinicalTrials.govpublic full text
Empagliflozin in Diuretic Refractory Ascites
liver cirrhosis, cirrhosis, ascites, ascites hepatic, sodium-glucose transporter 2 inhibitors, diuretic refractory, diuretic resistant, empagliflozin, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882264
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.